Trustees of Princeton University’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
Trustees of Princeton University's BOLD Position: Q1 2020 in Review
Trustees of Princeton University sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 27,522 shares — an estimated $1.65M sold.
Trustees of Princeton University first reported a position in BOLD in Q1 2019 and held it in 2 quarters. The position peaked at $1.65M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.
- Trustees of Princeton University reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
- Trustees of Princeton University sold 27,522 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.65M.
- Trustees of Princeton University first reported a position in Audentes Therapeutics, Inc in Q1 2019 and held it in 2 quarters.
- Trustees of Princeton University's Audentes Therapeutics, Inc position peaked at $1.65M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.
Based on Trustees of Princeton University's 13F filing for Q1 2020, filed 8 May 2020.